平成 25 年度報告 毒物劇物指定のための有害性情報の収集・ …
, 2013)：CRC 出版による物理化 学的性状に関するハンドブック Merck Index (Merck, 14th ed., 2006)：Merck and Company, Inc. による化学物質事典
Download 平成 25 年度報告 毒物劇物指定のための有害性情報の収集・ …
Information
Domain:
Source:
Link to this page:
Documents from same domain
NIHS 医薬品安全性情報 Vol.16 No.012018/0111/
www.nihs.go.jpCarafate’]の製品表示が改訂され， 販売名が[‘Carafate suspension’]から [‘Carafate oral suspension’]に変更さ
Guideline for the Development of Liposome Drug …
www.nihs.go.jp4 described in this document are also subject to other relevant notifications and guidelines. The active substances mentioned here include a low-molecular-weight chemical entity, a
Guideline for Bioequivalence Studies of Generic …
www.nihs.go.jp1 Guideline for Bioequivalence Studies of Generic Products for Topical Use July 7, 2003 局所皮膚適用製剤の後発医薬品のための 生物学的同等性試験ガイドライン
Since 1874 遺伝子治療用製品の開発における 国内 …
www.nihs.go.jp遺伝子治療の現状 海外の遺伝子治療の規制と国際調和 日本の遺伝子治療と関連規制 遺伝子治療指針の改正
Guideline for Bioequivalence Studies for Different ...
www.nihs.go.jp2 Section 1: Introduction This guideline describes the principles of procedures of bioequivalence studies for oral solid dosage forms that contains a different quantity of the active ingredient from an
Clinical Pharmacokinetic Studies of Pharmaceuticals
www.nihs.go.jp- 1 - Clinical Pharmacokinetic Studies of Pharmaceuticals This document is an informal translation of the official text that was promulgated in Japanese on
毒物及び劇物取締法Q＆A - nihs.go.jp
www.nihs.go.jp1 平成29年3月31日更新 毒物及び劇物取締法Q＆A 質問一覧 1．毒物及び劇物取締法について ..... 4
European Medicines Agency - NIHS
www.nihs.go.jpWhat is Quality Risk Management? • Proposed ICH Q9 definition: “Quality risk management is a systematic process for the identification, assessment
ICH Q9 ‘Quality Risk Management’ - NIHS
www.nihs.go.jpICH Q9 ‘Quality Risk Management’ - an industry view Peter H. Gough, Eli Lilly and Company
Risk Assessment and Management of Genotoxic ... …
www.nihs.go.jpRisk Assessment and Management of Genotoxic Impurities in Pharmaceuticals Masamitsu Honma, Ph.D. Division of Genetics and …
Related documents
Uranium Fact Sheet - Health Physics Society
hps.org1 Health Physics Society Specialists in Radiation Safety Uranium Fact Sheet Adopted: February 2011 Adopted from “A Citizen’s Guide to Uranium”
Environmental Assessment and Risk Analysis Element
www.state.nj.usEnvironmental Assessment and Risk Analysis Element WHITE PAPER SUMMARY January, 2003 Abstract The question of the potential for exposure to inorganic arsenic in water through dermal contact is important when providing
METHYL CHLORIDE - WHO
www.who.intThe International Programme on Chemical Safety (IPCS), established in 1980, is a joint venture of the United Nations Environment Programme (UNEP), the International Labour Organization (ILO), and the World Health Organization (WHO). The overall objectives of the IPCS are to establish the
Toxicological Profile for Styrene
www.atsdr.cdc.govThe ATSDR toxicological profile succinctly characterizes the toxicologic and adverse health effects infonnation for these toxic substances described therein.
NCEH/ATSDR Office of the Director
www.cdc.govNov 06, 2018 · Deputy Director for Non-Infectious Diseases (DDNID) Robin Ikeda, MD, MPH (RADM, USPHS) NCEH/ATSDR Office of the Director. Patrick Breysse, PhD, CIH Director
Technical Fact Sheet – 1,4-Dioxane - US EPA
www.epa.gov2 . Technical Fact Sheet – 1,4-Dioxane It is a by-product present in many goods, including paint strippers, dyes, greases, antifreeze and
Technical Fact Sheet - Perchlorate
www.epa.gov2 . Technical Fact Sheet – Perchlorate . What is perchlorate? (continued) Of the domestically produced (high grade) perchlorate, 90 percent is manufactured for use